| | Genomic instability in breast cancer: Pathogenesis and clinical implicationsReceived 24 February 2010; received in revised form 27 March 2010; accepted 2 April 2010. published online 20 April 2010. Abstract Breast cancer is a heterogeneous disease, appreciable by molecular markers, gene-expression profiles, and most recently, patterns of genomic alteration. In particular, genomic profiling has revealed three distinct patterns of DNA copy-number alteration: a “simple” type with few gains or losses of whole chromosome arms, an “amplifier” type with focal high-level DNA amplifications, and a “complex” type marked by numerous low-amplitude changes and copy-number transitions. The three patterns are associated with distinct gene-expression subtypes, and preferentially target different loci in the genome (implicating distinct cancer genes). Moreover, the different patterns of alteration imply distinct underlying mechanisms of genomic instability. The amplifier pattern may arise from transient telomere dysfunction, although new data suggest ongoing “amplifier” instability. The complex pattern shows similarity to breast cancers with germline BRCA1 mutation, which also exhibit “basal-like” expression profiles and complex-pattern genomes, implicating a possible defect in BRCA1-associated repair of DNA double-strand breaks. As such, targeting presumptive DNA repair defects represents a promising area of clinical investigation. Future studies should clarify the pathogenesis of breast cancers with amplifier and complex-pattern genomes, and will likely identify new therapeutic opportunities. Abbreviations: BER, base excision repair, BFB, breakage-fusion-bridge, CGH, comparative genomic hybridization, CIN, chromosome instability, CNA, copy-number alteration, DCIS, ductal carcinoma in situ, DM, double minute, DSB, double-strand break, ER, estrogen receptor, FISH, fluorescence in situ hybridization, HR, homologous recombination, HSR, homogeneously staining region, LOH, loss of heterozygosity, MSI, microsatellite instability, NER, nucleotide excision repair, NHEJ, non-homologous end joining, PR, progesterone receptor, ROS, reactive oxygen species, SNP, single nucleotide polymorphism a Department of Pathology, Stanford University School of Medicine, CCSR-3245A, 269 Campus Drive, Stanford, CA 94305-5176, USA b Department of Genetics, Stanford University School of Medicine, CCSR-3245A, 269 Campus Drive, Stanford, CA 94305-5176, USA Corresponding author. Tel.: +1 650 736 1987.
PII: S1574-7891(10)00023-2 doi:10.1016/j.molonc.2010.04.001 © 2010 Federation of European Biochemical Societies. Published by Elsevier Inc. All rights reserved. | |
|
|